KTTA Stock News

Popular stocks:

NVIDIA

TOP Stocks:

Shares of other companies:

Blue Apron Holdings

CMC Materials

Valneva SE

Alpine Immune Sciences

East Stone Acquisition

Global Payments

Pasithea Therapeutics (KTTA) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 5, 2023 (17:21)

Sector: Healthcare

The share price of Pasithea Therapeutics Corp. (KTTA) now

Latest session on the 5th of December for

Pasithea Therapeutics Corp. is negative

Trading Volume: 31457

Open: 0.31 / High: 0.319 / Low: 0.295

What analysts predict: $2

52-week High/Low: $1 / $0.286

50/200 Day Moving Average: $0.386 / $0.453

This figure corresponds to the Average Price over the previous 50/200 days. For Pasithea Therapeutics stocks, the 50-day moving average is the resistance level today.

For Pasithea Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Pasithea Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Pasithea Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Pasithea Therapeutics share be worth in 2024 - 2028?

When should I take profit in Pasithea Therapeutics stock? When should I record a loss on Pasithea Therapeutics stock? What are analysts' forecasts for Pasithea Therapeutics stock? What is the future of Pasithea Therapeutics stock? We forecast Pasithea Therapeutics stock performance using neural networks based on historical data on Pasithea Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Pasithea Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Pasithea Therapeutics shares. This happens once a day.

Historical and forecast chart of Pasithea Therapeutics stock

The chart below shows the historical price of Pasithea Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Pasithea Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Pasithea specializes in the discovery and development of new drugs for the treatment of psychiatric and neurological disorders. The company does not currently have a leading candidate drug in development. In the 24 months following its IPO, the company plans to discover three leading candidate compounds targeting the immune system’s link to certain mental disorders. An additional Pasithea business is to open depression clinics in the UK and the US, where doctors will administer ketamine intravenously to patients when indicated.

Pasithea Therapeutics daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 07	0.35	0.33	0.36	6.78
Dec 08	0.36	0.34	0.38	8.89
Dec 09	0.34	0.34	0.36	7.03
Dec 10	0.35	0.34	0.36	5.95
Dec 11	0.37	0.35	0.39	10.75
Dec 12	0.40	0.39	0.41	6.07
Dec 13	0.39	0.38	0.41	6.15
Dec 14	0.38	0.36	0.40	9.71
Dec 15	0.37	0.35	0.39	9.84
Dec 16	0.36	0.35	0.38	6.69
Dec 17	0.34	0.33	0.35	5.76
Dec 18	0.34	0.32	0.35	9.14
Dec 19	0.36	0.35	0.37	5.82
Dec 20	0.35	0.34	0.36	8.61
Dec 21	0.36	0.35	0.37	5.80
Dec 22	0.38	0.37	0.38	3.95
Dec 23	0.39	0.37	0.41	10.28
Dec 24	0.40	0.39	0.42	7.59
Dec 25	0.39	0.37	0.40	9.86
Dec 26	0.40	0.39	0.42	6.89
Dec 27	0.40	0.39	0.42	7.75
Dec 28	0.41	0.40	0.41	4.22
Dec 29	0.40	0.38	0.41	8.17
Dec 30	0.41	0.40	0.42	4.35
Dec 31	0.43	0.42	0.44	4.85
Jan 01	0.43	0.41	0.44	5.95
Jan 02	0.41	0.39	0.43	9.34
Jan 03	0.40	0.38	0.40	6.38
Jan 04	0.38	0.37	0.40	10.63
Jan 05	0.37	0.36	0.38	6.33

Pasithea Therapeutics Daily Price Targets

Pasithea Therapeutics Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $0.35.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 6.350%.
Pessimistic target level: 0.33
Optimistic target level: 0.36

Pasithea Therapeutics Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $0.36.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 8.163%.
Pessimistic target level: 0.34
Optimistic target level: 0.38

Pasithea Therapeutics Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $0.34.
Negative dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 6.571%.
Pessimistic target level: 0.34
Optimistic target level: 0.36

Pasithea Therapeutics Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $0.35.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 5.613%.
Pessimistic target level: 0.34
Optimistic target level: 0.36

Pasithea Therapeutics Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $0.37.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 9.708%.
Pessimistic target level: 0.35
Optimistic target level: 0.39

Pasithea Therapeutics Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $0.40.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 5.725%.
Pessimistic target level: 0.39
Optimistic target level: 0.41

KTTA (KTTA) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan.	0.31	0.26	0.35	27.76
Feb.	0.30	0.26	0.32	19.25
Mar.	0.33	0.31	0.38	17.24
Apr.	0.26	0.23	0.29	21.35
May.	0.24	0.22	0.27	18.43
Jun.	0.27	0.24	0.30	21.30
Jul.	0.33	0.28	0.37	25.36
Aug.	0.32	0.29	0.37	21.99
Sep.	0.32	0.26	0.37	28.25
Oct.	0.34	0.31	0.37	15.64
Nov.	0.32	0.29	0.33	12.70
Dec.	0.34	0.31	0.38	16.50

Full forecast for 2024

Pasithea Therapeutics forecast for this year

Pasithea Therapeutics Stock Prediction for Jan 2024

An downtrend is forecast for this month with an optimal target price of $0.305443. Pessimistic: $0.26. Optimistic: $0.35

Pasithea Therapeutics Stock Prediction for Feb 2024

An downtrend is forecast for this month with an optimal target price of $0.300953. Pessimistic: $0.26. Optimistic: $0.32

Pasithea Therapeutics Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $0.325601. Pessimistic: $0.31. Optimistic: $0.38

Pasithea Therapeutics Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $0.263379. Pessimistic: $0.23. Optimistic: $0.29

Pasithea Therapeutics Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $0.241808. Pessimistic: $0.22. Optimistic: $0.27

Pasithea Therapeutics Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $0.274307. Pessimistic: $0.24. Optimistic: $0.30

Pasithea Therapeutics Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $0.327879. Pessimistic: $0.28. Optimistic: $0.37

Pasithea Therapeutics Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $0.316862. Pessimistic: $0.29. Optimistic: $0.37

Pasithea Therapeutics Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $0.316197. Pessimistic: $0.26. Optimistic: $0.37

Pasithea Therapeutics Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $0.336117. Pessimistic: $0.31. Optimistic: $0.37

Pasithea Therapeutics Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $0.318471. Pessimistic: $0.29. Optimistic: $0.33

Pasithea Therapeutics Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $0.33586. Pessimistic: $0.31. Optimistic: $0.38

Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.32	0.29	0.34	12.77
Feb	0.37	0.34	0.40	15.07
Mar	0.34	0.31	0.36	12.97
Apr	0.31	0.28	0.34	19.01
May	0.34	0.29	0.37	20.85
Jun	0.35	0.33	0.40	18.69
Jul	0.42	0.38	0.45	13.52
Aug	0.41	0.38	0.47	18.14
Sep	0.38	0.34	0.42	21.11
Oct	0.39	0.32	0.42	22.52
Nov	0.41	0.38	0.47	19.08
Dec	0.49	0.44	0.53	18.58

Full forecast for 2025

Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.50	0.43	0.53	18.53
Feb	0.55	0.47	0.64	26.43
Mar	0.51	0.43	0.55	22.11
Apr	0.44	0.38	0.50	24.62
May	0.42	0.37	0.48	24.36
Jun	0.41	0.38	0.46	17.13
Jul	0.45	0.42	0.52	18.78
Aug	0.49	0.44	0.54	18.45
Sep	0.44	0.37	0.48	22.62
Oct	0.51	0.43	0.57	23.62
Nov	0.51	0.48	0.56	13.49
Dec	0.57	0.50	0.62	19.15

Full forecast for 2026

Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.68	0.57	0.73	21.53
Feb	0.74	0.64	0.81	20.22
Mar	0.67	0.59	0.79	25.17
Apr	0.63	0.54	0.70	21.86
May	0.60	0.57	0.68	17.03
Jun	0.55	0.48	0.62	22.80
Jul	0.60	0.54	0.64	15.01
Aug	0.68	0.59	0.75	21.43
Sep	0.75	0.64	0.86	25.68
Oct	0.72	0.66	0.84	21.47
Nov	0.71	0.65	0.81	19.70
Dec	0.79	0.69	0.83	16.16

Full forecast for 2027

Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2028

Month	Target	Pes.	Opt.	Vol., %
Jan	0.94	0.85	0.98	13.62
Feb	0.85	0.81	0.99	17.96
Mar	0.87	0.81	0.98	17.32
Apr	0.69	0.58	0.77	24.94
May	0.68	0.61	0.78	21.46
Jun	0.74	0.64	0.85	23.84
Jul	0.81	0.69	0.90	23.43
Aug	0.77	0.68	0.84	18.79
Sep	0.79	0.75	0.84	11.41
Oct	0.83	0.73	0.89	17.48
Nov	1.00	0.92	1.10	15.89
Dec	1.16	1.10	1.35	18.80

Full forecast for 2028

Pasithea Therapeutics information and performance

Pasithea Therapeutics Address

2110 NARCISSUS CT, VENICE, CA, US

Market Capitalization: 6 583 800 $

Market capitalization of the Pasithea Therapeutics Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KTTA shares in the company outstanding by the market price of one share.

EBITDA: -16 583 088 $

EBITDA of Pasithea Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.65

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 14.98

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.803

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 20836600

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Seagen Inc. (SGEN)

BridgeBio Pharma, Inc. (BBIO)

Bright Green Corporation (BGXX)

China Evergrande New Energy Vehicle Group Lim. (EVGRF)

Progenity, Inc. (PROG)

Moderna, Inc. (MRNA)

Absci Corporation (ABSI)

Novartis AG (NVS)

SmileDirectClub, Inc. (SDC)

ImmunoGen, Inc. (IMGN)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/KTTA.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/KTTA.svg"> Pasithea Therapeutics (KTTA) Stock Forecast for 2023 – 2026. Sell or Buy?